Abstract
AbstractTreatment of 3‐[4‐(2‐bromophenyl)‐2‐phenylbutyryl]‐4,4‐dimethyloxazolidin‐2‐one with LDA in THF launched a domino rearrangement sequence ending in the assembly of a tetracyclic cyclopentaoxazolo[3,2‐b]isoquinolin‐6‐one derivative. Two mechanisms involving an SRN1‐type process were proposed. EPR spectroscopic and 13C‐labelling experiments suggested that both were operative.(© Wiley‐VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2007)
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callSimilar Papers
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
